These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 513216

  • 1. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF, Wright GL, Rosato FE, Faulconer RJ.
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [Abstract] [Full Text] [Related]

  • 2. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA, Lamm DL, Radwin HM, Harrington JT.
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [Abstract] [Full Text] [Related]

  • 3. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG.
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [Abstract] [Full Text] [Related]

  • 4. Cellular immunity in bladder cancer patients.
    Guinan P, McKiel C, Flanagan M, Bhatti R, Pessis D, Ablin RJ.
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [Abstract] [Full Text] [Related]

  • 5. Some uses and limitations of immunologic testing in human patients.
    Lavergne JA.
    Bol Asoc Med P R; 1981 Apr; 73(4):141-5. PubMed ID: 6946780
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC.
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [Abstract] [Full Text] [Related]

  • 13. [In vitro migration inhibition of leukocytes from cancer patients by extracts of autologous and homologous tumors].
    Novikov DK, Adamenko GP.
    Dokl Akad Nauk SSSR; 1974 Dec; 217(3):715-8. PubMed ID: 4848926
    [No Abstract] [Full Text] [Related]

  • 14. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
    Bubeník J.
    Int Urol Nephrol; 1975 Dec; 7(4):297-302. PubMed ID: 1107249
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The detection of transitional cell bladder cancer antigen on established cell lines.
    Boxer RJ, Sofen H, Saxon A.
    Invest Urol; 1981 Sep; 19(2):70-4. PubMed ID: 7024183
    [No Abstract] [Full Text] [Related]

  • 19. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB, McCoy JL, Jerome LJ, Reddick R, Alford C, Tinley V, Herberman RB.
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [Abstract] [Full Text] [Related]

  • 20. [Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer].
    Xu JN, Li YT, Zhang ZY.
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):453-6, 508. PubMed ID: 4092537
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.